Biblio
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021:119437.
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol. 2020;89(Pt B):107088.